多发性骨髓瘤疫苗的研究进展 |
| |
引用本文: | 刘婷婷,牛挺. 多发性骨髓瘤疫苗的研究进展[J]. 国际输血及血液学杂志, 2016, 0(6): 526-529. DOI: 10.3760/cma.j.issn.1673-419X.2016.06.015 |
| |
作者姓名: | 刘婷婷 牛挺 |
| |
作者单位: | 1. 610041 成都,四川大学华西医院血液科血液疾病研究室;四川大学华西第四医院内科;2. 四川大学华西医院血液科血液疾病研究室, 成都,610041 |
| |
摘 要: | 多发性骨髓瘤(MM)疫苗具有耐受性较好,没有严重的不良反应等优点,近年来迅速发展,部分疫苗已经从动物实验进入临床试验阶段,并且其有望成为MM新的重要治疗方式之一.笔者根据国内外研究现状,现就MM疫苗的研究进展及其临床试验的发展情况进行综述.
|
关 键 词: | 多发性骨髓瘤 疫苗 临床试验 |
Research progress of multiple myeloma vaccines |
| |
Abstract: | Recently,multiple myeloma (MM) vaccines are rapid development and will be expected to become one of effective treatments in MM,because of their better tolerability and less serious adverse reactions,etc..And some vaccines have entered clinical trials from animal experiments.The authors review the research progress of MM vaccines and the development of their clinical trials in this paper,according to research status at home and abroad. |
| |
Keywords: | Multiple myeloma Vaccine Clinical trial |
本文献已被 万方数据 等数据库收录! |
|